Daniel J. Levangie, President, Surgical Products, 10% Owner at CYTYC CORP (CYTC), sold 200,000 shares at $49.86 ($10.0M) on 2007-10-05, disclosed to the SEC on 2007-10-09.
Scheduled sale ($10.0M) by President, Surgical Products, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.86 | 100,000 | $5.0M | 50.1% |
| 2 | $49.73 | 100,000 | $5.0M | 49.9% |
| Total | $49.80 avg | 200,000 | $10.0M | 100% |
| Filing → |
| EXAS | SELL | 2019-08-02 | $5.0M | — | Filing → |
| PODD | SELL | 2016-03-11 | $524K | — | Filing → |
| PODD | SELL | 2016-03-09 | $477K | — | Filing → |